Literature DB >> 28642969

Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.

Shogo Ida1, Katsutaro Morino2, Osamu Sekine1, Natsuko Ohashi1, Shinji Kume1, Tokuhiro Chano3, Kanako Iwasaki4, Norio Harada4, Nobuya Inagaki4, Satoshi Ugi1, Hiroshi Maegawa1.   

Abstract

AIMS/HYPOTHESIS: O-GlcNAcylation is characterised by the addition of N-acetylglucosamine to various proteins by O-GlcNAc transferase (OGT) and serves in sensing intracellular nutrients by modulating various cellular processes. Although it has been speculated that O-GlcNAcylation is associated with glucose metabolism, its exact role in whole body glucose metabolism has not been fully elucidated. Here, we investigated whether loss of O-GlcNAcylation globally and in specific organs affected glucose metabolism in mammals under physiological conditions.
METHODS: Tamoxifen-inducible global Ogt-knockout (Ogt-KO) mice were generated by crossbreeding Ogt-flox mice with R26-Cre-ERT2 mice. Liver, skeletal muscle, adipose tissue and pancreatic beta cell-specific Ogt-KO mice were generated by crossbreeding Ogt-flox mice with Alb-Cre, Mlc1f-Cre, Adipoq-Cre and Pdx1 PB-CreER™ mice, respectively. Glucose metabolism was evaluated by i.p. glucose and insulin tolerance tests.
RESULTS: Tamoxifen-inducible global Ogt-KO mice exhibited a lethal phenotype from 4 weeks post injection, suggesting that O-GlcNAcylation is essential for survival in adult mice. Tissue-specific Ogt deletion from insulin-sensitive organs, including liver, skeletal muscle and adipose tissue, had little impact on glucose metabolism under physiological conditions. However, pancreatic beta cell-specific Ogt-KO mice displayed transient hypoglycaemia (Ogt-flox 5.46 ± 0.41 vs Ogt-βKO 3.88 ± 0.26 mmol/l) associated with about twofold higher insulin secretion and accelerated adiposity, followed by subsequent hyperglycaemia (Ogt-flox 6.34 ± 0.32 vs Ogt-βKO 26.4 ± 2.37 mmol/l) with insulin depletion accompanied by beta cell apoptosis. CONCLUSIONS/
INTERPRETATION: These findings suggest that O-GlcNAcylation has little effect on glucose metabolism in insulin-sensitive tissues but plays a crucial role in pancreatic beta cell function and survival under physiological conditions. Our results provide novel insight into O-GlcNAc biology and physiology in glucose metabolism.

Entities:  

Keywords:  Apoptosis; Beta cells; Insulin resistance; Insulin secretion; O-GlcNAc transferase; O-GlcNAcylation; Post-translational modification

Mesh:

Substances:

Year:  2017        PMID: 28642969     DOI: 10.1007/s00125-017-4327-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

2.  Transcriptional control of adipose lipid handling by IRF4.

Authors:  Jun Eguchi; Xun Wang; Songtao Yu; Erin E Kershaw; Patricia C Chiu; Joanne Dushay; Jennifer L Estall; Ulf Klein; Eleftheria Maratos-Flier; Evan D Rosen
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

3.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny.

Authors:  R Shafi; S P Iyer; L G Ellies; N O'Donnell; K W Marek; D Chui; G W Hart; J D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.

Authors:  A Virkamäki; M C Daniels; S Hämäläinen; T Utriainen; D McClain; H Yki-Järvinen
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

5.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies.

Authors:  Carla M Weisend; Jean A Kundert; Elena S Suvorova; Justin R Prigge; Edward E Schmidt
Journal:  Genesis       Date:  2009-12       Impact factor: 2.487

7.  O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.

Authors:  Hai-Bin Ruan; Xuemei Han; Min-Dian Li; Jay Prakash Singh; Kevin Qian; Sascha Azarhoush; Lin Zhao; Anton M Bennett; Varman T Samuel; Jing Wu; John R Yates; Xiaoyong Yang
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

Review 8.  O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.

Authors:  Alexis K Nagel; Lauren E Ball
Journal:  Amino Acids       Date:  2014-08-31       Impact factor: 3.520

9.  O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis.

Authors:  Xun Wang; Zhihui Feng; Xueqiang Wang; Liang Yang; Shujun Han; Ke Cao; Jie Xu; Lin Zhao; Yong Zhang; Jiankang Liu
Journal:  Diabetologia       Date:  2016-03-18       Impact factor: 10.122

10.  Cardiomyocyte Ogt is essential for postnatal viability.

Authors:  Lewis J Watson; Bethany W Long; Angelica M DeMartino; Kenneth R Brittian; Ryan D Readnower; Robert E Brainard; Timothy D Cummins; Lakshmanan Annamalai; Bradford G Hill; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-01       Impact factor: 4.733

View more
  13 in total

1.  Role of nutrient-driven O-GlcNAc-post-translational modification in pancreatic exocrine and endocrine islet development.

Authors:  Daniel Baumann; Alicia Wong; Brian Akhaphong; Seokwon Jo; Samantha Pritchard; Ramkumar Mohan; Grace Chung; Ying Zhang; Emilyn U Alejandro
Journal:  Development       Date:  2020-04-12       Impact factor: 6.868

2.  O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesity.

Authors:  Yunfan Yang; Minnie Fu; Min-Dian Li; Kaisi Zhang; Bichen Zhang; Simeng Wang; Yuyang Liu; Weiming Ni; Qunxiang Ong; Jia Mi; Xiaoyong Yang
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

Review 3.  Posttranslational modifications in diabetes: Mechanisms and functions.

Authors:  Bin Chen; Jianing Zhong; Ang Hu; Haohong Zou
Journal:  Rev Endocr Metab Disord       Date:  2022-06-13       Impact factor: 9.306

4.  New Insights Into the Biology of Protein O-GlcNAcylation: Approaches and Observations.

Authors:  Toni Mueller; Xiaosen Ouyang; Michelle S Johnson; Wei-Jun Qian; John C Chatham; Victor Darley-Usmar; Jianhua Zhang
Journal:  Front Aging       Date:  2021-03-12

5.  O-linked N-Acetylglucosamine Transferase (OGT) regulates pancreatic α-cell function in mice.

Authors:  Ahmad Essawy; Seokwon Jo; Megan Beetch; Amber Lockridge; Eric Gustafson; Emilyn U Alejandro
Journal:  J Biol Chem       Date:  2021-01-15       Impact factor: 5.157

6.  Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivity.

Authors:  Hao Shi; Alexander Munk; Thomas S Nielsen; Morgan R Daughtry; Louise Larsson; Shize Li; Kasper F Høyer; Hannah W Geisler; Karolina Sulek; Rasmus Kjøbsted; Taylor Fisher; Marianne M Andersen; Zhengxing Shen; Ulrik K Hansen; Eric M England; Zhiyong Cheng; Kurt Højlund; Jørgen F P Wojtaszewski; Xiaoyong Yang; Matthew W Hulver; Richard F Helm; Jonas T Treebak; David E Gerrard
Journal:  Mol Metab       Date:  2018-02-24       Impact factor: 7.422

Review 7.  Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells.

Authors:  Nicholas Esch; Seokwon Jo; Mackenzie Moore; Emilyn U Alejandro
Journal:  J Diabetes Res       Date:  2020-12-16       Impact factor: 4.011

Review 8.  Involvement of O-GlcNAcylation in the Skeletal Muscle Physiology and Physiopathology: Focus on Muscle Metabolism.

Authors:  Matthias Lambert; Bruno Bastide; Caroline Cieniewski-Bernard
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-16       Impact factor: 5.555

9.  Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Ayumi Kaji; Ryosuke Sakai; Takafumi Osaka; Ryo Inoue; Saori Kashiwagi; Katsura Mizushima; Kazuhiko Uchiyama; Tomohisa Takagi; Yuji Naito; Michiaki Fukui
Journal:  J Diabetes Investig       Date:  2020-07-12       Impact factor: 4.232

Review 10.  Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Authors:  John C Chatham; Jianhua Zhang; Adam R Wende
Journal:  Physiol Rev       Date:  2020-07-30       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.